More than one billion people worldwide are affected with obstructive sleep apnea (OSA), and around 2.4 to 4.9% of males and 1 to 2 % of females in India are affected by OSA. Continuous positive airway pressure (CPAP) therapy is generally used to treat OSA. However, nowadays, many patients prefer hypoglossal nerve stimulator (HGNS), a surgically implantable device approved by the Food and Drug Administration, USA. HGNS stimulates the hypoglossal nerve and moves the tongue forward to reduce airway obstruction. Case presentation A 53-year-old male bodybuilder was admitted to a hospital for total shoulder arthroplasty.
The patient had a history of polycythemia, hypertension, and smoking marijuana daily. He also had OSA and HGNS implantation three years ago. However, he had not brought the remote controller for HGNS on the day of the surgery. Preparation for surgery Ultrasound-guided…
